Specific keynote: chemoprevention of ovarian cancer: the journey begins.
Ozols
Robert F
RF
Fox Chase Cancer Center.
Daly
Mary B
MB
Klein-Szanto
Andres
A
Hamilton
Thomas C
TC
Bast
Robert C
RC
Brewer
Molly A
MA
D016588:Anticarcinogenic Agents / Q000627:therapeutic use*; D003276:Contraceptives, Oral / Q000627:therapeutic use; D005260:Female; D017313:Fenretinide / Q000627:therapeutic use; D006801:Humans; D010051:Ovarian Neoplasms / Q000235:genetics / Q000517:prevention & control*; D010052:Ovariectomy; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors
D016588:Anticarcinogenic Agents; D003276:Contraceptives, Oral; D017313:Fenretinide